SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Government of Canada Release

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Nov 11, 2022 9:28am

125 Views

Post# 35091037

RE:Government of Canada Release

Great news !

Now lets see how quickly the company can start generating some sales.

If it has to happen locally first, sobeit. News will spread quickly.

Worst case they will reduce hospital over-crowding and give Doc's some much needed decision making tools going into the winter. Rali-Dx will, for sure, reduce some of the stress on the medical systems and quite likely save some Cdn lives.

MM

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record